Study of Precursor Hematological Malignancies to Assess the Relationship between Molecular Events of Progression and Clinical Outcome (PCROWD)

Trial Overview

Am I Eligible?

Participating US Centers

Dana-Farber Cancer Institute

This center is currently accepting patients.

Boston, MA


Northside Hospital

This center is currently accepting patients.

Atlanta, GA


West Michigan Cancer Center

This center is currently accepting patients.

Kalamazoo, MI

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Observational Trial

Trial Enrollment

1000 sparks required

Trial Sponsors
  • Dana-Farber Cancer Institute
Trial Collaborators
  • Leukemia and Lymphoma Society
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;